We are live on ! Find out more
INO icon

Inovio Pharmaceuticals

25 hedge funds and large institutions have $5.36M invested in Inovio Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 25 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.08% more ownership

Funds ownership: 0%0.08% (+0.08%)

Holders
25
Holders Change
+25
Holders Change %
% of All Funds
0.82%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
25
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.76M +$2.19M +72,292 New
Geode Capital Management
2
Geode Capital Management
Massachusetts
$504K +$399K +13,177 New
AWMDMG
3
Austin W. Marxe & David M. Greenhouse
New York
$476K +$378K +12,466 New
Morgan Stanley
4
Morgan Stanley
New York
$406K +$322K +10,633 New
Citigroup
5
Citigroup
New York
$228K +$181K +5,957 New
California Public Employees Retirement System
6
California Public Employees Retirement System
California
$195K +$155K +5,100 New
Northern Trust
7
Northern Trust
Illinois
$160K +$127K +4,183 New
JP Morgan Chase
8
JP Morgan Chase
New York
$121K +$96K +3,167 New
Bank of America
9
Bank of America
North Carolina
$90K +$71.3K +2,352 New
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$80K +$63.3K +2,088 New
Nomura Holdings
11
Nomura Holdings
Japan
$64K +$51.3K +1,692 New
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$57K +$45.5K +1,502 New
GC
13
Guggenheim Capital
Illinois
$49K +$39.1K +1,290 New
Bank of New York Mellon
14
Bank of New York Mellon
New York
$43K +$33.9K +1,117 New
State Street
15
State Street
Massachusetts
$42K +$32.8K +1,082 New
Prudential Financial
16
Prudential Financial
New Jersey
$16K +$12.3K +406 New
Commonwealth Equity Services
17
Commonwealth Equity Services
Massachusetts
$15K +$12.2K +402 New
BA
18
BlackRock Advisors
Delaware
$13K +$10.2K +337 New
UAS
19
United Asset Strategies
New York
$10K +$7.97K +263 New
CIC
20
Carnegie Investment Counsel
Ohio
$8K +$6.3K +208 New
LBC
21
Lawrence B. Cohen
$8K +$6.3K +208 New
VFS
22
VSR Financial Services
Kansas
$8K +$6.3K +208 New
AWMS
23
Advocacy Wealth Management Services
Georgia
$2K +$1.91K +63 New
Deutsche Bank
24
Deutsche Bank
Germany
+$303 +10 New
PSI
25
Pinnacle Summer Investments
Virginia
+$303 +10 New

INO Hedge Fund Activity: Q2 2013 in Review

25 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Inovio Pharmaceuticals (INO) for Q2 2013, worth a combined $5.36M.

Buyers outnumbered sellers: 25 funds opened new INO positions and 0 closed out — a net gain of 25 holders — while 0 added to existing stakes and 0 trimmed.

  • 25 institutional investors held Inovio Pharmaceuticals (INO) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $5.36M of Inovio Pharmaceuticals stock for Q2 2013.
  • 25 funds opened new Inovio Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +25 holders.

Based on aggregated 13F filings for Q2 2013.